Wednesday, March 23, 2016

"A 'Roadmap' for Navigating Patient Advocacy," FDA Article

My comment to the FDA's Facebook post:
The best way to navigate patient safety is to inform all medical personnel that they MUST READ product information sheets; e.g., if a patient enters the hospital and declares they are allergic to corn, the medical staff SHOULD KNOW that IV fluid w/corn-derived dextrose CANNOT be administered to the corn-allergic patient.
...
BAXTER LABORATORIES: WARNING ABOUT USING CORN-DERIVED DEXTROSE IV FLUID ON THE CORN-ALLERGIC PATIENT
Excerpt from their product information sheet: "Solutions containing dextrose should be used with caution, if at all, in patients with known allergy to corn or corn products.”  https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016679s104,016682s105,016692s095,019367s026lbl.pdf

No comments:

Post a Comment